19GOCNewsSpring

The GOC News

SPRING 2019

Dr. Robert Lotocki, BSc, MD, FRCSC, FSOGC, FACOG is a professor in the Department of Obstetrics and Gynaecology and Reproductive Sciences at the University of Manitoba. Dr. Lotocki is being recognized with this award because of his dedication and leadership to the field of gynecologic oncology, his role as a mentor and teacher, as well as his dedicated efforts towards the development of the specialty itself within Canada. As a testament to this, his numerous ex-fellows are influential gynecologic oncologists in South America, Saudi Arabia and Canada. Dr. Lotocki’s contribution to research in gynecologic oncology is well known. Over the past 30 years Dr. Lotocki has published articles in various Journals (i.e. Journal of Obstetrics and Gynaecology and Gynecologic Oncology Journal). He has received multiple grants to participate in several CCTG and other multicentre trials to further knowledge about gynecologic cancers and their treatment. In addition, Dr. Lotocki has contributed book chapters, web content, clinical practice guidelines and material for both Cancer Care GOC Honours Dr. Robert J. Lotocki Recipient of GOC’s Presidential Medal Award

Words from the President

Dear Colleagues, It’s April and that signals the beginning of conference season once again. Where did the year go? Coming up fast at the end of April, the 19th Annual CPD meeting in Toronto. We have an exciting agenda encompassing major contemporary issues for our speciality, including PARP inhibitor usage, vulvar cancer updates, and of course the ongoing controversy of MIS in cervical cancer. The 18th Annual Leadership speaker is Dr. Attila Lorincz who has extensive experience in the field of Molecular Epidemiology. Dr. Lorincz pioneered the use of HPV DNA testing for clinical screening, and then produced the first HPV test that was FDA approved. Dr. Lorincz will also be our guest speaker at CPD day and at the Molecular Biology Course. June will be here before we know it and I can’t wait to welcome you to my home town of Halifax for the AGM. This promises to be an engaging meeting with a record number of submitted abstracts.TheTumor Board is sure to bring interesting cases for discussion with Drs. Patti Power and Anna Cameron. The Battle Royale - where two heavyweights, Dr. Amit Oza and Dr. Al Covens, duke it out over the topic of TPN in the palliative setting – should provide a provocative discussion. The Presidential Symposium will be presented By Dr. Bill Cliby from the Mayo Clinic. Dr. Cliby will be addressing the timely topic of selection criteria for primary cytoreduction surgery in advanced ovarian cancer. Dr. Cliby will also be joining local faculty for the inaugural Biennial Cytoreductive Multivisceral Cadaver Course. This will provide hands-on

Manitoba and the Cervical Cancer Screening Program in Manitoba. It is because of this program that many people have had their cervical dysplasia or early cervical cancer discovered in order to prevent the spread and advancement of disease. Congratulations Dr. Lotocki! We look forward to celebrating with you at the Awards Dinner on June 14th in Halifax.

CONTINUED ON PAGE 2

MORE INSIDE

02 BRCA Collaborative

07 GOC/SOGC Advocacy Program

14 Trials Update

16 Communities of Practice

Made with FlippingBook - Online magazine maker